临床决策。前列腺癌筛查。
Clinical decisions. Screening for prostate cancer.
机构信息
Brigham and Women’s Hospital and Dana–Farber Cancer Institute, Boston, USA.
出版信息
N Engl J Med. 2012 Aug 16;367(7):e11. doi: 10.1056/NEJMclde1209426.
Abstract
This interactive feature addresses the diagnosis or management of a clinical case. A case vignette is followed by specific clinical options, neither of which can be considered either correct or incorrect. In short essays, experts in the field then argue for each of the options. Readers can participate in forming community opinion by choosing one of the options and, if they like, providing their reasons.
摘要
本互动功能旨在解决临床病例的诊断或管理问题。病例简述后会提供具体的临床选择，这些选择都不能被视为正确或错误。然后，该领域的专家会以短文的形式分别为每个选择进行论证。读者可以通过选择其中一个选项并（如果愿意）提供理由来参与形成社区意见。
相似文献
1
Clinical decisions. Screening for prostate cancer.临床决策。前列腺癌筛查。
N Engl J Med. 2012 Aug 16;367(7):e11. doi: 10.1056/NEJMclde1209426.
2
Clinical decisions. Prostate cancer screening--polling results.临床决策。前列腺癌筛查——民意调查结果。
N Engl J Med. 2012 Oct 25;367(17):e25. doi: 10.1056/NEJMclde1212034.
3
Decline in Prostate Cancer Screening by Primary Care Physicians: An Analysis of Trends in the Use of Digital Rectal Examination and Prostate Specific Antigen Testing.初级保健医生中前列腺癌筛查的下降：数字直肠检查和前列腺特异性抗原检测使用趋势分析。
J Urol. 2016 Oct;196(4):1047-52. doi: 10.1016/j.juro.2016.03.171. Epub 2016 Apr 6.
4
Digital rectal examination can detect early prostate cancer.直肠指检可检测出早期前列腺癌。
Evid Based Med. 2015 Jun;20(3):119. doi: 10.1136/ebmed-2014-110162. Epub 2015 Mar 10.
5
Is the digital rectal exam any good as a prostate cancer screening test?直肠指检作为前列腺癌筛查测试效果如何？
Br J Gen Pract. 2024 Feb 29;74(740):137-139. doi: 10.3399/bjgp24X736677. Print 2024 Mar.
6
Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men.数字直肠检查与血清前列腺特异性抗原在前列腺癌早期检测中的比较：6630 例男性多中心临床试验结果。
J Urol. 2017 Feb;197(2S):S200-S207. doi: 10.1016/j.juro.2016.10.073. Epub 2016 Dec 22.
7
[Screening and prevention of prostate cancer].[前列腺癌的筛查与预防]
MMW Fortschr Med. 2010 May 13;152(19):37-9. doi: 10.1007/BF03366554.
8
Re: prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-up.关于：在随机化前列腺、肺、结肠直肠和卵巢癌筛查试验中的前列腺癌筛查：13年随访后的死亡率结果
J Natl Cancer Inst. 2012 May 16;104(10):793; author reply 793-4. doi: 10.1093/jnci/djs205. Epub 2012 Apr 5.
9
The Melbourne Consensus Statement on the early detection of prostate cancer.《墨尔本前列腺癌早期检测共识声明》。
BJU Int. 2014 Feb;113(2):186-8. doi: 10.1111/bju.12556.
10
Guideline of guidelines: prostate cancer screening.指南之指南：前列腺癌筛查
BJU Int. 2014 Sep;114(3):323-5. doi: 10.1111/bju.12854.
引用本文的文献
1
Communicating risk in active surveillance of localised prostate cancer: a protocol for a qualitative study.局部前列腺癌主动监测中的风险沟通：一项定性研究方案
BMJ Open. 2017 Oct 5;7(10):e017372. doi: 10.1136/bmjopen-2017-017372.
2
A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer.一项针对放射肿瘤学家和泌尿科医生的全国性调查，内容是关于前列腺癌前列腺特异性抗原筛查的建议。
BJU Int. 2014 May;113(5b):E106-11. doi: 10.1111/bju.12422. Epub 2014 Jan 17.
本文引用的文献
1
Quality-of-life effects of prostate-specific antigen screening.前列腺特异性抗原筛查对生活质量的影响。
N Engl J Med. 2012 Aug 16;367(7):595-605. doi: 10.1056/NEJMoa1201637.
2
Radical prostatectomy versus observation for localized prostate cancer.根治性前列腺切除术与观察等待治疗局限性前列腺癌的比较。
N Engl J Med. 2012 Jul 19;367(3):203-13. doi: 10.1056/NEJMoa1113162.
3
What the U.S. Preventive Services Task Force missed in its prostate cancer screening recommendation.美国预防服务工作组在其前列腺癌筛查建议中遗漏的内容。
Ann Intern Med. 2012 Jul 17;157(2):137-8. doi: 10.7326/0003-4819-157-2-201207170-00463.
4
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.前列腺癌筛查：美国预防服务工作组推荐声明。
Ann Intern Med. 2012 Jul 17;157(2):120-34. doi: 10.7326/0003-4819-157-2-201207170-00459.
5
Prostate-cancer mortality after PSA screening.前列腺特异性抗原（PSA）筛查后的前列腺癌死亡率
N Engl J Med. 2012 Jun 7;366(23):2229; author reply 2230-1. doi: 10.1056/NEJMc1204298.
6
Prostate-cancer mortality at 11 years of follow-up.前列腺癌死亡率随访 11 年后。
N Engl J Med. 2012 Mar 15;366(11):981-90. doi: 10.1056/NEJMoa1113135.
7
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.随机前列腺癌、肺癌、结直肠癌和卵巢癌筛查试验中的前列腺癌筛查：13 年随访后的死亡率结果。
J Natl Cancer Inst. 2012 Jan 18;104(2):125-32. doi: 10.1093/jnci/djr500. Epub 2012 Jan 6.
8
Radical prostatectomy versus watchful waiting in early prostate cancer.根治性前列腺切除术与早期前列腺癌的观察等待。
N Engl J Med. 2011 May 5;364(18):1708-17. doi: 10.1056/NEJMoa1011967.
9
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.哥德堡随机人群前列腺癌筛查试验的死亡率结果。
Lancet Oncol. 2010 Aug;11(8):725-32. doi: 10.1016/S1470-2045(10)70146-7. Epub 2010 Jul 2.
Zotero 插件